Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Abiomed a Bad-News Buy Right Now?

TheMotleyFool

0 0

2019 has been a rotten year for Abiomed's (NASDAQ: ABMD) investors. Shares of the temporary heart pump maker have fallen more than 40% since January in response to a slew of negative headlines. Meanwhile, Abiomed's revenue and net income have continued to grow. The combination has pulled the company's valuation down to the lowest level in years.

Is Abiomed a "bad news" buy, or are shares too risky to touch?

Image source: Getty Images.

Source Fool.com

Like: 0

ABMD

Share